UniTest, Inc.

As of March 31, 2026, UniTest, Inc. carries a market capitalization of 320.65B, placing it among publicly traded companies globally. Its enterprise value stands at 333.54B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

UniTest, Inc.'s next confirmed earnings release is scheduled for November 18, 2026.

As of March 31, 2026, UniTest, Inc. has 20.33M shares outstanding.

These figures are as of March 31, 2026. The price-to-sales ratio is 2.91, and the price-to-book ratio stands at 3.31.

These figures are as of March 31, 2026. The EV/Sales ratio of 3.03 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 333.54B versus a market cap of 320.65B, with the gap driven by net debt and cash on the balance sheet.

As of March 31, 2026, UniTest, Inc. maintains a current ratio of 1.46, meaning it holds 1.5x the short-term assets needed to cover near-term liabilities.

Over the twelve months ended March 31, 2026, UniTest, Inc. posted a negative return on equity (ROE) of -16.14, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -8.88, reflecting losses generated across the asset base. The company generates approximately 559.37M in revenue per employee across its workforce of 197.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 3.80 indicates how many times UniTest, Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended March 31, 2026, UniTest, Inc. recorded 736.60M in income tax expense. The company reported a pretax loss of -17.79B and -17.01B in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 23, 2026, UniTest, Inc.'s stock has declined approximately 35.02% over the past 52 weeks. The 50-day moving average sits at 11,654.20, while the 200-day moving average is 14,300.05.

Over the twelve months ended March 31, 2026, UniTest, Inc. generated 110.20B in revenue and converted that into -17.01B in net income, yielding earnings per share of -911.19. EBITDA reached -19.63B, while operating income came in at -19.62B.

As of March 31, 2026, UniTest, Inc. holds 36.08B in cash and equivalents against 52.25B in total debt, resulting in a net debt position of 34.84B. Total book value stands at 96.90B, with working capital of 35.49B providing operational flexibility.

UniTest, Inc. produced -6.88B in operating cash flow over the twelve months ended March 31, 2026. After subtracting -2.08B in capital expenditures, free cash flow totaled -8.95B - equivalent to -440.37 per share.

Over the twelve months ended March 31, 2026, UniTest, Inc. posted a gross margin of 15.19, reflecting its pricing power and cost economics. The operating margin of -17.81 and net profit margin of -15.43 provide insight into operational efficiency.

These figures cover the twelve months ended March 31, 2026. Free cash flow yield is negative at -2.79: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -2.88, meaning UniTest, Inc. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

UniTest, Inc.'s most recent stock split took place on August 4, 2010 with a 858:971 split ratio.

As of March 31, 2026, UniTest, Inc. has an Altman Z-Score of 3.07, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.